Temozolomide Capsule
Product Images NDC 70301-2003

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 70301-2003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opko Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Temo Structure)

Chemical structure of temozolomide showing its molecular configuration with heterocyclic rings, amide group, and methyl substituent.*

FDA Label Image

Figure (Figure)

Kaplan-Meier curves chart depicting overall survival percentage over time in months for patients with newly diagnosed glioblastoma. The chart compares two treatment arms: RT + TMZ (solid line) and RT Only (dashed line). A table below the chart shows the number of patients at risk for each treatment arm at specified time points.*

FDA Label Image

Label05 (Label05)

Packaging label for Temozolomide Capsules, USP, 20 mg by OPKO Pharmaceuticals, LLC. The label indicates oral administration with warnings such as 'Hazardous Drug' and storage instructions (store at 25°C with excursions permitted to 15-30°C). The package contains 5 individual sachets, each with one capsule. Barcodes and a revision date of 02/2026 are visible.*

FDA Label Image

Label06 (Label06)

Label for Temozolomide Capsule USP 20 mg distributed by OPKO Pharmaceuticals, LLC. The front panel includes the drug name, strength, and distributor address. It also contains a warning about the drug being hazardous and instructions to read accompanying directions carefully. The back panel includes space for lot and expiration dates along with a barcode. The label is designed for single 1-capsule oral use.*

FDA Label Image

Label07 (Label07)

Temozolomide Capsules, USP 20 mg oral capsules packaging label by OPKO Pharmaceuticals, LLC. The label includes dosage strength 20 mg per capsule, storage instructions at 25°C with permitted excursions, and warnings indicating it is a hazardous drug for prescription use only. The package contains 14 individual sachets, each with one capsule, and has a barcode with NDC 70301-2003-2.*

FDA Label Image

Label08 (Label08)

Label for Temozolomide Capsule USP 20 mg displays front and back views. The front side shows the product name, strength (20 mg highlighted in yellow), distributor OPKO Pharmaceuticals, LLC with address, and a warning about hazardous drug status and careful reading of accompanying directions. The back side includes a barcode and placeholders for lot number and expiration date. The label dimensions and layout are marked with metric measurements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.